BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10608102)

  • 1. Brief report: frequency of maternal cocaine use during pregnancy and infant neurobehavioral outcome.
    Schuler ME; Nair P
    J Pediatr Psychol; 1999 Dec; 24(6):511-4. PubMed ID: 10608102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure.
    Eyler FD; Behnke M; Garvan CW; Woods NS; Wobie K; Conlon M
    Neurotoxicol Teratol; 2001; 23(5):399-411. PubMed ID: 11711242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
    Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
    Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance.
    Tronick EZ; Frank DA; Cabral H; Mirochnick M; Zuckerman B
    Pediatrics; 1996 Jul; 98(1):76-83. PubMed ID: 8668416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):237-41. PubMed ID: 9445497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of prenatal cocaine exposure on full-term infant neurobehavioral functioning.
    Morrow CE; Bandstra ES; Anthony JC; Ofir AY; Xue L; Reyes ML
    Neurotoxicol Teratol; 2001; 23(6):533-44. PubMed ID: 11792523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing language skills of cocaine-exposed infants.
    Singer LT; Arendt R; Minnes S; Salvator A; Siegel AC; Lewis BA
    Pediatrics; 2001 May; 107(5):1057-64. PubMed ID: 11331686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine addiction in mothers: potential effects on maternal care and infant development.
    Strathearn L; Mayes LC
    Ann N Y Acad Sci; 2010 Feb; 1187():172-83. PubMed ID: 20201853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status.
    Coles CD; Platzman KA; Smith I; James ME; Falek A
    Neurotoxicol Teratol; 1992; 14(1):23-33. PubMed ID: 1593976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.
    Serino Ma D; Peterson Md BS; Rosen Md TS
    J Dual Diagn; 2018; 14(3):158-170. PubMed ID: 29694295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal effects of prenatal cocaine use on mother-child interactions at ages 3 and 5 years.
    Mansoor E; Morrow CE; Accornero VH; Xue L; Johnson AL; Anthony JC; Bandstra ES
    J Dev Behav Pediatr; 2012 Jan; 33(1):32-41. PubMed ID: 22157442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome.
    Jacobson SW; Chiodo LM; Sokol RJ; Jacobson JL
    Pediatrics; 2002 May; 109(5):815-25. PubMed ID: 11986441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal cocaine use and maternal depression: effects on infant neurobehavior.
    Salisbury AL; Lester BM; Seifer R; Lagasse L; Bauer CR; Shankaran S; Bada H; Wright L; Liu J; Poole K
    Neurotoxicol Teratol; 2007; 29(3):331-40. PubMed ID: 17258430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine exposure and developmental outcome from birth to 6 months.
    Behnke M; Eyler FD; Garvan CW; Wobie K; Hou W
    Neurotoxicol Teratol; 2002; 24(3):283-95. PubMed ID: 12009484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal cocaine exposure and child welfare outcomes.
    Doris JL; Meguid V; Thomas M; Blatt S; Eckenrode J
    Child Maltreat; 2006 Nov; 11(4):326-37. PubMed ID: 17043317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal drug exposure and maternal and infant feeding behaviour.
    LaGasse LL; Messinger D; Lester BM; Seifer R; Tronick EZ; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Finnegan LP; Maza PL; Liu J
    Arch Dis Child Fetal Neonatal Ed; 2003 Sep; 88(5):F391-9. PubMed ID: 12937043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prenatal cocaine use on neonatal neurobehavioral status.
    Richardson GA; Hamel SC; Goldschmidt L; Day NL
    Neurotoxicol Teratol; 1996; 18(5):519-28. PubMed ID: 8888016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in utero substance exposure on infant neurobehavior.
    Napiorkowski B; Lester BM; Freier MC; Brunner S; Dietz L; Nadra A; Oh W
    Pediatrics; 1996 Jul; 98(1):71-5. PubMed ID: 8668415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between maternal cocaine use during pregnancy and physiological regulation in 4- to 8-week-old infants: an examination of possible mediators and moderators.
    Schuetze P; Eiden RD
    J Pediatr Psychol; 2006; 31(1):15-26. PubMed ID: 15788714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure.
    Suri R; Hellemann G; Stowe ZN; Cohen LS; Aquino A; Altshuler LL
    J Clin Psychiatry; 2011 Jul; 72(7):1002-7. PubMed ID: 21672498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.